Yüklüyor......

Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy

BACKGROUND: to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT). METHODS: 131 patients affected by intermediate-risk PCa were treated with HyRT at the total dose of 54,75 Gy in 15 fraction plus 9 months of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Radiat Oncol
Asıl Yazarlar: Bracci, Stefano, Osti, Mattia F., Agolli, Linda, Bertaccini, Luca, De Sanctis, Vitaliana, Valeriani, Maurizio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4898326/
https://ncbi.nlm.nih.gov/pubmed/27276878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0656-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!